Protalix BioTherapeutics
PLX
PLX
33 hedge funds and large institutions have $8.72M invested in Protalix BioTherapeutics in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% less capital invested
Capital invested by funds: $12.5M → $8.72M (-$3.75M)
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.13M | |
| 2 | +$1.8M | |
| 3 | +$1.78M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$954K |
| 5 |
AGC
Angelo Gordon & Co
New York
|
+$470K |
Top Sellers
| 1 | -$7.43M | |
| 2 | -$3.56M | |
| 3 | -$221K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$29K |
| 5 |
SIM
Spark Investment Management
New York
|
-$15.7K |